Brown Advisory’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-20,263
Closed -$2.01M 1080
2019
Q3
$2.01M Sell
20,263
-3,696
-15% -$351K 0.01% 514
2019
Q2
$2.21M Sell
23,959
-10,162
-30% -$965K 0.01% 507
2019
Q1
$3.22M Sell
34,121
-32,456
-49% -$2.84M 0.01% 528
2018
Q4
$4.27M Sell
66,577
-8,241
-11% -$608K 0.01% 440
2018
Q3
$6.7M Sell
74,818
-401
-0.5% -$35.4K 0.02% 396
2018
Q2
$5.97M Sell
75,219
-4,230
-5% -$351K 0.02% 406
2018
Q1
$7.09M Sell
79,449
-10,614
-12% -$1.02M 0.02% 349
2017
Q4
$9.4M Sell
90,063
-1,179
-1% -$133K 0.03% 325
2017
Q3
$13.3M Sell
91,242
-1,275
-1% -$174K 0.04% 269
2017
Q2
$12M Sell
92,517
-1,907
-2% -$234K 0.04% 281
2017
Q1
$11.7M Sell
94,424
-4,657
-5% -$557K 0.04% 270
2016
Q4
$11.5M Buy
99,081
+21,834
+28% +$2.43M 0.04% 269
2016
Q3
$8.07M Buy
77,247
+14,902
+24% +$1.61M 0.03% 308
2016
Q2
$6.15M Buy
62,345
+5,990
+11% +$620K 0.02% 332
2016
Q1
$5.64M Buy
56,355
+5,562
+11% +$573K 0.02% 346
2015
Q4
$6.08M Buy
50,793
+6,846
+16% +$792K 0.02% 341
2015
Q3
$4.75M Buy
43,947
+1,225
+3% +$152K 0.02% 361
2015
Q2
$4.94M Buy
42,722
+3,368
+9% +$385K 0.02% 349
2015
Q1
$4.54M Sell
39,354
-2,804
-7% -$335K 0.01% 367
2014
Q4
$4.72M Buy
42,158
+932
+2% +$98.3K 0.01% 354
2014
Q3
$3.91M Sell
41,226
-324
-0.8% -$29.2K 0.01% 363
2014
Q2
$3.57M Sell
41,550
-5,804
-12% -$441K 0.01% 379
2014
Q1
$3.31M Buy
47,354
+720
+2% +$57K 0.01% 382
2013
Q4
$3.94M Buy
46,634
+3,944
+9% +$312K 0.01% 346
2013
Q3
$3.29M Buy
42,690
+14,642
+52% +$1.03M 0.01% 356
2013
Q2
$1.64M Buy
+28,048
New +$1.69M 0.01% 417

Other funds holding CELG

Brown Advisory's CELG Position: Q4 2019 in Review

Brown Advisory sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 20,263 shares — an estimated $2.01M sold.

Brown Advisory first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $13.3M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Brown Advisory reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Brown Advisory sold 20,263 Celgene Corp shares in Q4 2019, an estimated $2.01M.
  • Brown Advisory first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Brown Advisory's Celgene Corp position peaked at $13.3M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Brown Advisory's 13F filing for Q4 2019, filed 14 Feb 2020.